Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Operating Leases (2023 - 2025)

Profound Medical (PROF) has 3 years of Operating Leases data on record, last reported at $72000.0 in Q2 2025.

  • For Q2 2025, Operating Leases changed N/A year-over-year to $72000.0; the TTM value through Jun 2025 reached $72000.0, changed N/A, while the annual FY2024 figure was $203000.0, 59.72% down from the prior year.
  • Operating Leases reached $72000.0 in Q2 2025 per PROF's latest filing, down from $136000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $504000.0 in Q4 2023 and bottomed at $72000.0 in Q2 2025.
  • Average Operating Leases over 3 years is $228750.0, with a median of $169500.0 recorded in 2024.
  • The widest YoY moves for Operating Leases: up 59.72% in 2024, down 59.72% in 2024.
  • A 3-year view of Operating Leases shows it stood at $504000.0 in 2023, then crashed by 59.72% to $203000.0 in 2024, then plummeted by 64.53% to $72000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $72000.0 in Q2 2025, $136000.0 in Q1 2025, and $203000.0 in Q4 2024.